1. Home
  2. CLGN vs DFNS Comparison

CLGN vs DFNS Comparison

Compare CLGN & DFNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

SELL

Current Price

$3.94

Market Cap

5.2M

Sector

Health Care

ML Signal

SELL

Logo T3 Defense Inc. Common Stock

DFNS

T3 Defense Inc. Common Stock

HOLD

Current Price

$3.90

Market Cap

4.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLGN
DFNS
Founded
2004
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
4.2M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
CLGN
DFNS
Price
$3.94
$3.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.1K
★ 477.1K
Earning Date
11-25-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 261.46
EPS
★ N/A
N/A
Revenue
N/A
★ $5,913,461.00
Revenue This Year
N/A
N/A
Revenue Next Year
$25.00
$33.09
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.26
$3.52
52 Week High
$4.78
$335.00

Technical Indicators

Market Signals
Indicator
CLGN
DFNS
Relative Strength Index (RSI) 57.00 31.01
Support Level $0.34 $3.70
Resistance Level $3.91 $7.36
Average True Range (ATR) 0.35 0.60
MACD -0.06 0.17
Stochastic Oscillator 45.19 11.46

Price Performance

Historical Comparison
CLGN
DFNS

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

About DFNS T3 Defense Inc. Common Stock

T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. The company operates as a strategic platform, building a portfolio of mission-critical suppliers and technology companies. Its portfolio includes businesses involved in defense and aerospace technologies, such as AI software, unmanned aerial systems, electro-mechanical manufacturing, and motion control systems, as well as activities in technology distribution, licensing, and defense infrastructure development through joint ventures.

Share on Social Networks: